National Medical Products Administration, Announcement on Further Clarifying Matters Relevant to the Production of Imported Medical Device Products by Enterprises in Mainland China (Draft for Comments)

国家药品监督管理局关于进一步明确进口医疗器械产品在中国境内企业生产有关事项的公告 (征求意见稿)

November 18, 2024 | BY

Susan Mok

NMPA clarifies the qualifications of a foreign-invested enterprise that may produce imported medical devices in China

Issued: October 29, 2024


Main contents: A foreign-invested enterprise as mentioned in the Announcement may be either an enterprise established by the registrant of an imported medical device or an enterprise under the common control of the same de facto controller with the imported medical device registrant. That is to say, that the Announcement applies to matters relevant to the production in mainland China of a Class II or Class III product with an imported medical device registration certificate by a foreign-invested enterprise established by the imported medical device registrant or by one that is under the common control of the same de facto controller with it.

This premium content is reserved for
China Law & Practice Subscribers.

  • A database of over 3,000 essential documents including key PRC legislation translated into English
  • A choice of newsletters to alert you to changes affecting your business including sector specific updates
  • Premium access to the mobile optimized site for timely analysis that guides you through China's ever-changing business environment
For enterprise-wide or corporate enquiries, please contact our experienced Sales Professionals at +44 (0)203 868 7546 or [email protected]